Surface Engineering of Escherichia coli–Derived OMVs as Promising Nano-Carriers to Target EGFR-Overexpressing Breast Cancer Cells

癌细胞 化学 免疫原性 细胞质 细胞生物学 受体 赫拉 癌症研究 细胞 抗体 癌症 生物 生物化学 免疫学 遗传学
作者
Zahra Sepahdar,Mehran Miroliaei,Saeid Bouzari,Vahid Khalaj,Mona Salimi
出处
期刊:Frontiers in Pharmacology [Frontiers Media]
卷期号:12: 719289-719289 被引量:22
标识
DOI:10.3389/fphar.2021.719289
摘要

Bacterial outer membrane vesicles (OMVs) have recently drawn a great deal of attention due to their therapeutic efficiency and ability to target specific cells. In the present study, we sought to probe engineered OMVs as novel and promising carriers to target breast cancer cells. Following the fusion of the affiEGFR-GALA structure to the C-terminal of ClyA as an anchor protein, the ClyA-affiEGFR-GALA construct was successfully expressed on the surface of ∆msbB/∆pagP E. coli W3110-derived OMVs. Morphological features of the engineered and wild-type OMVs were identical. The engineered OMVs induced no endotoxicity, cytotoxicity, or immunogenicity, indicating the safety of their application. These OMVs could specifically bind to EGF receptors of MDA-MB-468 cells expressing high levels of EGFR and not to those with low levels of EGFR (HEK293T cells). Interestingly, despite a lower binding affinity of the engineered OMVs relative to the positive control Cetuximab, it was strong enough to identify these cells. Moreover, confocal microscopy revealed no uptake of the modified OMVs by the EGFR-overexpressing cells in the presence of EGFR competitors. These results suggest that OMVs might internalize into the cells with EGF receptors, as no OMVs entered the cells with any EGFR expression or those pretreated with EGF or Cetuximab. Regarding the EGFR-binding affinity of the engineered OMVs and their cellular uptake, they are presented here as a potential carrier for cell-specific drug delivery to treat a wide variety of cancer cells. Interestingly, the engineered OMVs are capable of reaching the cytoplasm while escaping the endosome due to the incorporation of a fusogenic GALA peptide in the construct.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
yang完成签到 ,获得积分10
1秒前
stc发布了新的文献求助50
3秒前
young完成签到 ,获得积分10
3秒前
完美世界的应助被wydd采纳,获得10
4秒前
滟滟完成签到,获得积分10
5秒前
6秒前
MADAO发布了新的文献求助30
6秒前
艺术家不看日落的应助被tx采纳,获得100
7秒前
无聊的依白完成签到,获得积分10
8秒前
TTT完成签到,获得积分10
10秒前
11秒前
AsahiKokura214完成签到,获得积分10
12秒前
文献互助1完成签到,获得积分10
12秒前
aajhajkahna的应助被lyh采纳,获得10
13秒前
彩霞完成签到,获得积分10
14秒前
超级大肥宅完成签到,获得积分10
14秒前
15秒前
李健的应助被李志豪采纳,获得10
16秒前
16秒前
zzz发布了新的文献求助10
17秒前
博修发布了新的文献求助10
18秒前
温暖书雪完成签到,获得积分10
18秒前
科研通AI65的应助被舒南晴采纳,获得10
18秒前
Pony完成签到,获得积分0
18秒前
19秒前
即兴完成签到,获得积分10
19秒前
19秒前
19秒前
油盐不进的四季豆完成签到 ,获得积分10
19秒前
zzz关闭了zzz的文献求助
20秒前
21秒前
21秒前
可爱的函函的应助被学霸颖采纳,获得10
21秒前
21秒前
21秒前
stc发布了新的文献求助10
22秒前
wydd发布了新的文献求助10
22秒前
听海与你发布了新的文献求助10
24秒前
Mokwepa完成签到,获得积分20
25秒前
Zx发布了新的文献求助10
25秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571584
关于积分的说明 21818707
捐赠科研通 7778124
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557710
邀请新用户注册赠送积分活动 2479621